Bioforce Nanosciences Holdings reported total assets of $2.39M and total liabilities of $0.08M for the quarter ended Jun 2026. This balance sheet covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.03M | 0.01M | 0.01M | 0.01M | 750.00 | 734.00 | 686.00 | 654.00 | 686.00 | 638.00 | 640.00 | 667.00 | 0.00M | 862.00 | 0.01M | 905.00 | 784.00 | 786.00 | 0.01M | 307.00 | ||||||||||||
| Cash & Current Investments | 0.03M | 0.01M | 0.01M | 0.01M | 750.00 | 734.00 | 686.00 | 654.00 | 686.00 | 638.00 | 640.00 | 667.00 | 0.00M | 862.00 | 0.01M | 905.00 | 784.00 | 786.00 | 0.01M | 307.00 | ||||||||||||
| Receivables - NetNet Receivables | ||||||||||||||||||||||||||||||||
| Receivables | ||||||||||||||||||||||||||||||||
| Prepaid Assets | 70.00 | 40.00 | 10.00 | 2.15M | ||||||||||||||||||||||||||||
| Current Assets | 0.03M | 0.01M | 0.01M | 0.01M | 750.00 | 734.00 | 686.00 | 654.00 | 686.00 | 638.00 | 640.00 | 667.00 | 0.00M | 862.00 | 0.01M | 905.00 | 784.00 | 786.00 | 0.01M | 2.15M | ||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||||
| Non-Current Assets | 0.23M | |||||||||||||||||||||||||||||||
| Assets | 0.03M | 0.01M | 0.01M | 0.01M | 750.00 | 734.00 | 686.00 | 654.00 | 686.00 | 638.00 | 640.00 | 667.00 | 0.00M | 862.00 | 0.01M | 905.00 | 784.00 | 786.00 | 0.01M | 2.39M | ||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||||
| Accounts Payables | 435.00 | 0.01M | 400.00 | 844.00 | 398.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | |||||||||||||
| Notes Payables | 0.12M | 0.12M | 0.15M | 0.16M | 0.16M | |||||||||||||||||||||||||||
| Payables | 0.12M | 0.12M | 0.15M | 0.16M | 0.17M | 398.00 | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | ||||||||||||
| Accumulated Expenses | 0.64M | 0.75M | 0.86M | 0.96M | 1.07M | 1.17M | 1.28M | 1.39M | 1.49M | 1.60M | 1.70M | 1.81M | 1.91M | 2.02M | 0.21M | 0.32M | 0.42M | 0.51M | 0.61M | 0.02M | ||||||||||||
| Total Current Liabilities | 0.77M | 0.87M | 1.01M | 1.12M | 1.23M | 1.35M | 1.48M | 1.59M | 1.71M | 1.82M | 1.95M | 2.07M | 2.18M | 2.30M | 0.28M | 0.38M | 0.50M | 0.62M | 0.73M | 0.08M | ||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||||
| Total Liabilities | 0.77M | 0.87M | 1.01M | 1.12M | 1.23M | 1.35M | 1.48M | 1.59M | 1.71M | 1.82M | 1.95M | 2.07M | 2.18M | 2.30M | 0.28M | 0.38M | 0.50M | 0.62M | 0.73M | 0.08M | ||||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||||
| Total Debt | 0.12M | 0.12M | 0.15M | 0.16M | 0.16M | |||||||||||||||||||||||||||
| Common Equity | -0.74M | -0.86M | -0.99M | -1.11M | -1.23M | -1.35M | -1.48M | -1.59M | -1.70M | -1.82M | -1.95M | -2.06M | -2.18M | -2.30M | -0.26M | -0.38M | -0.50M | -0.62M | -0.72M | 2.30M | ||||||||||||
| Liabilities and Shareholders Equity | 0.03M | 0.01M | 0.01M | 0.01M | 750.00 | 734.00 | 686.00 | 654.00 | 686.00 | 638.00 | 640.00 | 667.00 | 0.00M | 862.00 | 0.01M | 905.00 | 784.00 | 786.00 | 0.01M | 2.39M | ||||||||||||
| Retained Earnings | -159.55M | -159.67M | -159.80M | -159.92M | -160.04M | -160.16M | -160.29M | -160.40M | -160.52M | -160.63M | -160.76M | -160.87M | -161.00M | -161.12M | -162.05M | -162.18M | -162.29M | -162.41M | -162.51M | -162.28M | ||||||||||||
| Preferred Shares | 100.00M | 100.00M |